e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Pulmonary hypertension in hypoxic lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of established and exercise induced pulmonary hypertension in COPD
J. Hilde, I. Skjorten, S. Humerfelt, V. Hansteen, M. Melsom, J. Hisdal, K. Steine (Oslo, Lorenskog, Norway)
Source:
Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Session:
Pulmonary hypertension in hypoxic lung disease
Session type:
Thematic Poster Session
Number:
2372
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Hilde, I. Skjorten, S. Humerfelt, V. Hansteen, M. Melsom, J. Hisdal, K. Steine (Oslo, Lorenskog, Norway). Prevalence of established and exercise induced pulmonary hypertension in COPD. Eur Respir J 2011; 38: Suppl. 55, 2372
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Pulmonary hypertension reduces exercise tolerance in COPD
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension
Source: Eur Respir J, 50 (3) 1700784; 10.1183/13993003.00784-2017
Year: 2017
Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002
Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients
Source: Eur Respir J 2004; 24 : 580-586
Year: 2004
Right ventricular response during exercise in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015
Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Stroke volume augmentation during exercise in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Pathophysiology of exercise limitation in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005
Pulmonary hypertension and exercise performance in advanced COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Frequency of exercise induced pulmonary hypertension after pulmonary embolism
Source: Eur Respir J 2006; 28: Suppl. 50, 401s
Year: 2006
Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Smoking induced pulmonary vascular remodelling in patients with mild COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
Source: Eur Respir J 2002; 19: 632-638
Year: 2002
Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Comparing cardiopulmonary responses to incremental exercise in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension
Source: Annual Congress 2011 - Altered mechanisms during exercise in disease
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept